Carbamazepine-induced hyponatremia in patients with mental retardation

Theodore A. Kastner, D. L. Friedman, W. S. Pond

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Carbamazepine-induced hyponatremia has been reported in 21.7% of 61 patients with mental retardation who received the medication for a variety of reasons. We studied 40 patients with mental retardation receiving carbamazepine to determine the prevalence of hyponatremia. Overall, hyponatremia was found in only 5.0% of these patients. Correlations with sodium level and carbamazepine dose, serum drug level, and concomitant neuroleptic and anticonvulsant polytherapy were also examined. Treatment with carbamazepine resulted in a statistically, but not clinically, significant decrease in serum sodium levels in patients receiving anticonvulsant polytherapy. Deceases in serum sodium were not related to carbamazepine dose or blood levels. Only one patient with underlying schizophrenia and psychogenic polydipsia demonstrated clinically significant hyponatremia during carbamazepine therapy.

Original languageEnglish (US)
Pages (from-to)536-540
Number of pages5
JournalAmerican Journal on Mental Retardation
Volume96
Issue number5
StatePublished - 1992
Externally publishedYes

Fingerprint

Hyponatremia
Carbamazepine
schizophrenia
Intellectual Disability
medication
drug
Sodium
Anticonvulsants
Psychogenic Polydipsia
Serum
Antipsychotic Agents
Mental Retardation
Schizophrenia
Therapeutics
Pharmaceutical Preparations
Dose

ASJC Scopus subject areas

  • Rehabilitation
  • Education
  • Health Professions(all)

Cite this

Kastner, T. A., Friedman, D. L., & Pond, W. S. (1992). Carbamazepine-induced hyponatremia in patients with mental retardation. American Journal on Mental Retardation, 96(5), 536-540.

Carbamazepine-induced hyponatremia in patients with mental retardation. / Kastner, Theodore A.; Friedman, D. L.; Pond, W. S.

In: American Journal on Mental Retardation, Vol. 96, No. 5, 1992, p. 536-540.

Research output: Contribution to journalArticle

Kastner, TA, Friedman, DL & Pond, WS 1992, 'Carbamazepine-induced hyponatremia in patients with mental retardation', American Journal on Mental Retardation, vol. 96, no. 5, pp. 536-540.
Kastner, Theodore A. ; Friedman, D. L. ; Pond, W. S. / Carbamazepine-induced hyponatremia in patients with mental retardation. In: American Journal on Mental Retardation. 1992 ; Vol. 96, No. 5. pp. 536-540.
@article{ee949df6e3004a2d9fcc84fe589cba8f,
title = "Carbamazepine-induced hyponatremia in patients with mental retardation",
abstract = "Carbamazepine-induced hyponatremia has been reported in 21.7{\%} of 61 patients with mental retardation who received the medication for a variety of reasons. We studied 40 patients with mental retardation receiving carbamazepine to determine the prevalence of hyponatremia. Overall, hyponatremia was found in only 5.0{\%} of these patients. Correlations with sodium level and carbamazepine dose, serum drug level, and concomitant neuroleptic and anticonvulsant polytherapy were also examined. Treatment with carbamazepine resulted in a statistically, but not clinically, significant decrease in serum sodium levels in patients receiving anticonvulsant polytherapy. Deceases in serum sodium were not related to carbamazepine dose or blood levels. Only one patient with underlying schizophrenia and psychogenic polydipsia demonstrated clinically significant hyponatremia during carbamazepine therapy.",
author = "Kastner, {Theodore A.} and Friedman, {D. L.} and Pond, {W. S.}",
year = "1992",
language = "English (US)",
volume = "96",
pages = "536--540",
journal = "American Journal on Intellectual and Developmental Disabilities",
issn = "1944-7515",
publisher = "American Association on Intellectual and Developmental Disabilities",
number = "5",

}

TY - JOUR

T1 - Carbamazepine-induced hyponatremia in patients with mental retardation

AU - Kastner, Theodore A.

AU - Friedman, D. L.

AU - Pond, W. S.

PY - 1992

Y1 - 1992

N2 - Carbamazepine-induced hyponatremia has been reported in 21.7% of 61 patients with mental retardation who received the medication for a variety of reasons. We studied 40 patients with mental retardation receiving carbamazepine to determine the prevalence of hyponatremia. Overall, hyponatremia was found in only 5.0% of these patients. Correlations with sodium level and carbamazepine dose, serum drug level, and concomitant neuroleptic and anticonvulsant polytherapy were also examined. Treatment with carbamazepine resulted in a statistically, but not clinically, significant decrease in serum sodium levels in patients receiving anticonvulsant polytherapy. Deceases in serum sodium were not related to carbamazepine dose or blood levels. Only one patient with underlying schizophrenia and psychogenic polydipsia demonstrated clinically significant hyponatremia during carbamazepine therapy.

AB - Carbamazepine-induced hyponatremia has been reported in 21.7% of 61 patients with mental retardation who received the medication for a variety of reasons. We studied 40 patients with mental retardation receiving carbamazepine to determine the prevalence of hyponatremia. Overall, hyponatremia was found in only 5.0% of these patients. Correlations with sodium level and carbamazepine dose, serum drug level, and concomitant neuroleptic and anticonvulsant polytherapy were also examined. Treatment with carbamazepine resulted in a statistically, but not clinically, significant decrease in serum sodium levels in patients receiving anticonvulsant polytherapy. Deceases in serum sodium were not related to carbamazepine dose or blood levels. Only one patient with underlying schizophrenia and psychogenic polydipsia demonstrated clinically significant hyponatremia during carbamazepine therapy.

UR - http://www.scopus.com/inward/record.url?scp=0026538071&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026538071&partnerID=8YFLogxK

M3 - Article

C2 - 1562311

AN - SCOPUS:0026538071

VL - 96

SP - 536

EP - 540

JO - American Journal on Intellectual and Developmental Disabilities

JF - American Journal on Intellectual and Developmental Disabilities

SN - 1944-7515

IS - 5

ER -